Indian J Pharm Close
 

Figure 2: Changes in fasting plasma glucose (FPG) level (mg/dL) in groups A, B, and C. FPG levels (mean± SD) in Group A are 155.7 ± 7.5, 142.7 ± 6.9, 124.8 ±11.2 at weeks 4,8, 12 respectively; in Group B are 145.1 ± 8.9, 131.2± 10.2, 105.6 ± 7.8 at weeks 4,8, 12 respectively; in Group C are132.2 ± 9.2, 114.8 ± 8.6, 89.9 ± 9.1 at weeks 4,8, 12 respectively. * P < 0.05-Weeks 4, 8,12 versus week 0 in groups A, B, and C. Intergroup comparison of FPG levels at weeks 4,8, and 12: At weeks 4, 8, and12- (#P < 0.05-Groups B, C vs. Group A), (##P < 0.05-Groups C vs. Group B). Statistical test used was analysis of variance followed by Tukey's honestly significant difference test

Figure 2: Changes in fasting plasma glucose (FPG) level (mg/dL) in groups A, B, and C. FPG levels (mean± SD) in Group A are 155.7 ± 7.5, 142.7 ± 6.9, 124.8 ±11.2 at weeks 4,8, 12 respectively; in Group B are 145.1 ± 8.9, 131.2± 10.2, 105.6 ± 7.8 at weeks 4,8, 12 respectively; in Group C are132.2 ± 9.2, 114.8 ± 8.6, 89.9 ± 9.1 at weeks 4,8, 12 respectively. * <i>P</i> < 0.05-Weeks 4, 8,12 versus week 0 in groups A, B, and C. Intergroup comparison of FPG levels at weeks 4,8, and 12: At weeks 4, 8, and12- (<sup>#</sup><i>P</i> < 0.05-Groups B, C vs. Group A), (<sup>##</sup><i>P</i> < 0.05-Groups C vs. Group B). Statistical test used was analysis of variance followed by Tukey's honestly significant difference test